ASTION PHARMA A/S: Financial statements 2025
CVR: 34224781
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.
- Gross Profit
- DKK -18,071
- Profit/Loss
- DKK -164,736
- Equity
- DKK -5,950,429
- Total Assets
- DKK 782,899
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -18K | -165K | -6M | 0 |
| 2024 | - | -116K | -246K | -5.8M | - |
| 2023 | - | 132K | 11K | -5.5M | - |
| 2022 | - | 206K | 25K | -5.6M | - |
| 2021 | - | -1.4M | -6.3M | -5.6M | - |
Official annual report
How creditworthy is ASTION PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ASTION PHARMA A/S has published its annual report for 2024. Gross profit came to DKK -115,576, and the net result was DKK -246,248.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.